The FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...

Dr. Marwan G. Fakih discussed the FDA approval of Lumakras with Vectibix for third-line treatment of KRAS G12C-mutated ...

On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...

Paul Nghiem, MD, PhD, and the Nghiem Lab have championed innovations in MCC treatment, delivering new treatment options, ...

In the ALEXANDRA/IMpassion030 trial, Tecentriq (atezolizumab) added to postoperative chemotherapy was not found to improve treatment outcomes for patients with high-risk early-stage triple-negative ...

One of the UK's most senior radiotherapy experts has spoken publicly for the first time about living with incurable cancer.Professor Adrian Crellin ...

Alphamab Oncology (Stock Code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ('CSPC') (Stock Code: 1093.HK) jointly announced that anti-HER2 biparatopic antibody-drug conjugate (ADC) JSKN003 has ...

Marine-derived lipids, including omega-3 fatty acids, are emerging as potential game-changers in cancer therapy. Research ...

On Wednesday, family and friends of a Madison man gathered at Masters Golf Tournament to watch as a non-profit granted his ...

Five students from Ouachita Baptist University’s Patterson School of Natural Sciences have published research in the nationally-recognized scientific journal, “microPublication Biology.” The students ...

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended 3 biosimilars and new indications for reference biologics, moving them closer to final European ...

"We have discovered a molecular switch that can revert the fate of cancer cells," said biologist Kwang-Hyun Cho.